Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
114 hedge funds and large institutions have $317M invested in Surmodics in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 46 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
16% more capital invested
Capital invested by funds: $274M → $317M (+$43.1M)
3% more funds holding
Funds holding: 111 → 114 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.02% less ownership
Funds ownership: 85.75% → 84.73% (-1%)
22% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 46
32% less call options, than puts
Call options by funds: $395K | Put options by funds: $581K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$4.54M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.45M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.6M |
| 4 |
BlackRock
New York
|
+$977K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$733K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$4.34M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.74M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$1.22M |
| 4 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$1.16M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$791K |
SRDX Hedge Fund Activity: Q2 2017 in Review
114 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2017, worth a combined $317M — up 16% from $274M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SRDX positions and 8 closed out — a net gain of 3 holders — while 36 added to existing stakes and 46 trimmed.
The largest buyer was Trigran Investments, adding an estimated $4.54M. The largest seller was JP Morgan Chase, cutting an estimated $4.34M.
- 114 institutional investors held Surmodics (SRDX) as of Q2 2017, up from 111 in Q1 2017.
- Funds reported $317M of Surmodics stock for Q2 2017, up 16% quarter-over-quarter.
- 11 funds opened new Surmodics positions in Q2 2017 and 8 closed out, a net change of +3 holders.
- The largest Surmodics buyer in Q2 2017 was Trigran Investments, an estimated $4.54M added.
- The largest Surmodics seller in Q2 2017 was JP Morgan Chase, an estimated $4.34M sold.
Based on aggregated 13F filings for Q2 2017.